Articles On Actinogen Medical (ASX:ACW)

Title Source Codes Date
April Winners Column: Resources re-takes the mantle, led by one stock that gained nearly 500pc

Google April 2021 and the first things you’ll find isn’t ASX winners but questions about COVID-19. Just another month in the pandemic, right? Well, yes and no. On one hand the vaccine race continues across the world – far slower than we’d l...

Stockhead ACW 1 day ago
Here’s why Pharmaxis (ASX:PXS) shares are trending on the ASX

Summary Pharmaxis Ltd and Charlie Teo Foundation have identified a new drug that shows promise in tackling a deadly form of brain cancer. Pharmaxis’ PXS-5505 will be a part of preclinical testing to assess its efficacy for glioblastoma...

Kalkine Media ACW 3 days ago
Capital Raisings Recap: Nearly $10 billion has already been raised in 2021

The capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the first four months of the year. Across 325 deals, ASX companies have raised $9.878 billion in capital amidst IPOs, placements and rights issues....

Stockhead ACW 3 days ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Stockhead ACW 2 weeks ago
Why is the Actinogen (ASX:ACW) share price falling 17% today?

Actinogen Medical Ltd (ASX: ACW) shares are tumbling today after the company released its quarterly activity report and strategic update this morning. At the time of writing, the Actinogen share price is sliding a whopping 17.24% to 4.8 ce...

Motley Fool ACW 2 weeks ago
10 at 10: Investors are closely monitoring these ASX stocks this morning

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead ACW 2 weeks ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

Stockhead ACW 3 weeks ago
Actinogen (ASX:ACW) share price surges 23% today, 165% this year

Actinogen Medical Ltd (ASX: ACW) shares are rocketing higher today and have now gained 165% since the start of 2021. At the time of writing, the Actinogen share price is trading 23.26% higher for the day so far at 5.3 cents, up from just 2...

Motley Fool ACW 3 weeks ago
March Winners Column: Oil is FINALLY on the boil

March got off to a rough start, with ASX small caps suffering their worst week since October and the Small Ords Index falling into the red on the year. But it got better. US punters received another stimmy cheque in the mail from President...

Stockhead ACW 1 month ago
Hot Money Monday: These are the most in-demand stocks on the ASX right now

Stockhead’s Hot Money Monday analysis is based on the Relative Strength Index (RSI) — a technical gauge which measures how trading momentum is affecting the price action. A reading of 70 is seen as the level at which a company may have been...

Stockhead ACW 1 month ago
Check Up: Oneview leads healthcare sector after ‘investor awareness’ pact

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Stockhead ACW 1 month ago
Bill Ketelbey from Actinogen Medical (ASX:ACW)

Actinogen Medical CEO Dr Bill Ketelbey speaks at the Switzer Small and Micro Cap Virtual Investor Day 2020.

Switzer ACW 4 months ago
Actinogen Medical (ASX:ACW) share price jumps on patent news

The Actinogen Medical Ltd (ASX: ACW) share price jumped 4.5% on open this morning, after the company announced it has filed two new patent applications to strengthen and extend its intellectual property (IP) portfolio.   What does Actinoge...

Motley Fool ACW 5 months ago
Actinogen reveals its next clinical trial plans

Actinogen (ASX:ACW) has reveals plans for two clinical trials it will conduct next year - against MCI due to Alzheimers ... Read More The post Actinogen reveals its next clinical trial plans appeared first on Stockhead.

Stockhead ACW 6 months ago
Bell Potter raising for Alzheimer's drug hopeful Actinogen

ASX-listed Actinogen Medical is in front of potential investors seeking a $10 million equity injection to fund a trial for its Alzheimer's drug. 

AFR ACW 6 months ago
Actinogen Medical announces the appointment of new CFO

Actinogen Medical (ASX:ACW’) has announced the appointment of Mr Jeff Carter as its new chief financial officer (CFO).

BiotechDispatch ACW 7 months ago
Closing Bell: Today’s biggest small cap movers on the ASX

A quick wrap of the key winners and losers on Tuesday, June 2. Data is taken after the market closes at 4pm EST. Stocks highlighted in yellow made potentially market-moving announcements during the day.   Code Name Price % Chg...

Stockhead ACW 11 months ago
Dr Boreham’s Crucible: Why Invex has all the right ingredients to possibly become a takeover target

From the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a condition characterised by debilitating chronic daily headaches and in some cases severe vision impairment. It’s a poorly treated condi...

Stockhead ACW 11 months ago
Are we mortgaging the future as COVID-19 closes clinical trials?

The COVID-19 pandemic has led to 527 clinical trials being shut down in Australia and New Zealand the last two months, up 36 per cent on the prior two months as many organisations deem the patient risk of exposure to be too high. Globally,...

Stockhead ACW 1 year ago
10 at 10: These ASX stocks are shining bright this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead ACW 1 year ago
Leaving out ladies could be costing biotechs a lot of money

With the world focused on the outcome of clinical trials for a COVID-19 vaccine, new research may add a new layer of complexity to a trial process that mainly uses male animals and male humans in the development stages for drugs. A team of...

Stockhead ACW 1 year ago
Dementia sufferers in Australia will hit 1 million, can these small caps come up with a treatment?

Dementia already affects hundreds of thousands of people in Australia, and it’s only going to get worse if a medical miracle is not forthcoming. The term relates to brain diseases, including Alzheimers, that impact a person’s ability to thi...

Stockhead ACW 1 year ago
Brain health is complicated, but these ASX small caps are trying to keep it in shape

You may have heard the saying “it’s not brain surgery” in the context of trying to prove something easy. Well there is a reason  — our brains are among the most difficult parts of our body to treat. There are a few ASX small caps trying to...

Stockhead ACW 1 year ago
The 10 ASX stocks that more than tripled in a single day in 2019

Who said you have to be patient to net a hefty return on an investment? There are 10 ASX small caps that tripled (gained 200 per cent or more) in a day in 2019. Stockhead recaps the lucky companies and the reason for their show-stopping per...

Stockhead ACW 1 year ago
These are the 22 small cap biotechs closest to bringing a drug to market

There are no shortage of small cap health and biotech companies listed on the ASX — around 140 or so — but less than 25 are anywhere close to their ultimate dream of bringing a drug successfully to market, a Stockhead analysis has found. Ta...

Stockhead ACW 1 year ago
Small cap successes highlighted at the Austrralian Microcap Investment Conference

The 10th Annual Australian Microcap Investment Conference will be held on Tuesday 22 October 2019 over two days at the Sofitel Melbourne on Collins. The Conference is Australia’s largest and most comprehensive emerging company investment ev...

FinFeed ACW 1 year ago
Investors flocking to Melbourne for southern hemisphere’s biggest biotech investment conference

Investors, brokers, high-ranking delegates, big pharma and Aussie small caps will all be sharing a room at the upcoming AusBiotech Invest & Partnering 2019 event in late October. The southern hemisphere’s biggest biotech investment even...

Stockhead ACW 1 year ago
Core Lithium appoints new director

The Board of advanced Australian lithium developer Core Lithium (ASX: CXO) has announced the appointment of Malcolm McComas as a non-executive director, effective immediately. Mr McComas joins the Board as Core strengthens the organisation...

Investor Insight ACW 1 year ago
Picking The One Cent Wonders That Could Become Dollar Dazzlers

By Tim Boreham, Editor, The New Criterion When a stock is trading at a fraction of a cent, it’s usually a message for investors to abandon all hope and sell for the tax losses while they can. But ‘penny dreadful’ shares can sometimes rise...

FNArena ACW 1 year ago
Triplets: The 10 ASX small caps that more than tripled in a day in 2019

In 2019, 10 stocks have gained more than 200 per cent in a single day. Stockhead recaps these stocks, why they gained and where they are now.   10. AssetOwl (ASX: AO1) +225% (16 April) A fellow micro-cap gave AssetOwl a massive leg up back...

Stockhead ACW 1 year ago
Hot Money Monday: The most in-demand stocks on the ASX right now

Each Monday, Stockhead recaps which stocks are heavily demanded by investors — or running hot. Stockhead uses the Relative Strength Index (RSI), a technical gauge which measures how trading momentum is affecting the price action. A reading...

Stockhead ACW 1 year ago
Dr Boreham’s Crucible: Actinogen on the mend after a near-death experience

It wasn’t quite a case of ‘Lazarus with a triple bypass’, but a recovery of miraculous proportions did happen in the biotech sector last week as Actinogen (ASX:ACW) jagged some remarkable efficacy results from what otherwise a bog-standard...

Stockhead ACW 1 year ago
Picking The One Cent Wonders That Could Become Dollar Dazzlers

ShareCafePicking The One Cent Wonders That Could Become Dollar Dazzlers When a stock is trading at a fraction of a cent, it’s usually a message for investors to abandon all hope and sell for the tax losses while they can. But ‘penny drea...

ShareCafe ACW 1 year ago
Rat's Rant: What's hot, what's not and ... more biotech winners

What's hot Immuron Limited (ASX:IMC) Immuron closed up 66% to finish at 17.5c on $3.69 million stock traded. The reason for the rise was a new research agreement with the Naval Medical Research Centre (NMRC), Silver Spring, MD, USA. AU$5.5...

FinFeed ACW 1 year ago
Rise & Shine: What you need to know before the ASX opens

On Stockhead today: are semiconductors about to pick up again, California’s first pot cafe opens, biotech losers’ remarkable comeback, and angel investment firm Investible closes with $22m round. But first:   The day ahead Today the Austral...

Stockhead ACW 1 year ago
Check-up: Remarkable recovery has two big biotech losers talk of the town

The three best-performing health and biotech companies in the past fortnight have all seen their shares fly on the back of positive clinical trial results — and the top two are companies trying to recover from previously disappointing trial...

Stockhead ACW 1 year ago
2 Hot Health Care Stocks – Actinogen, Resapp

The Australian benchmark index S&P/ASX200, last traded on 2 October 2019, at 6639.9 points, down by 1.5 percent from the prior close. Also, S&P/ASX200 Health Care (Sector) last traded on 2 October 2019 at 35,821.4 points, dipping do...

Kalkine Media ACW 1 year ago
Actinogen’s shares surge 460% after Xanamem success

On Tuesday, Actinogen Medical (ASX:ACW) released extremely promising results from the XanaHES (Xanamem in Healthy Elderly Subjects) trial. Investors recognised the potentially company transforming nature of the results when they were releas...

FinFeed ACW 1 year ago
Rat's Rant: What's hot, what's not and... the Bali anniversary

On 1 October 2005, I was only 20 metres away from a large bomb that went off in the heart of Kuta. The 2005 Bali bombings were a series of terrorist attacks across two sites in Jimbaran Bay and in Kuta - 30km away from each other, both in s...

FinFeed ACW 1 year ago
10 at 10: These ASX stocks are bouncing higher this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead ACW 1 year ago
Rise & Shine: What you need to know before the ASX opens

On Stockhead today: Tim Treadgold on why gold miner Pantoro is a stock to watch, milk stocks in healthier shape thanks to Bellamy’s, Barry FitzGerald talks Salt Lake Pot Ash in Explorer’s Podcast and just how much do neobanks scare the Big...

Stockhead ACW 1 year ago
Why Actinogen Medical shares climbed 466% on excitement over an Alzheimer’s treatment

The Actinogen Medical Ltd (ASX: ACW) share price is up 466% today from 0.9 cents to 5.1 cents after the biotech researcher reported positive clinical trial results for its Xanamem drug designed to treat cognitive impairment in the elderly....

Motley Fool ACW 1 year ago
Actinogen Medical announces ‘breakthrough’ study results for Alzheimer’s drug Xanamem

Actinogen Medical (ASX: ACW) has announced “breakthrough” results from its XanaHES higher dose safety study first initiated last year. The results reaffirm the foundational hypothesis that reducing cortisol levels can improve cognition with...

SmallCaps ACW 1 year ago
10 at 10: These ASX stocks are on the dancefloor this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead ACW 1 year ago
Rise & Shine: What you need to know before the ASX opens

On Stockhead today: Aussie small caps trying to tackle the opioid crisis, which car manufacturers will survive the EV revolution, Barry FitzGerald looks at upcoming juniors, and how South Australian small caps are putting themselves back on...

Stockhead ACW 1 year ago
Rise & Shine: What you need to know before the ASX opens

On Stockhead today: our report on the 100 best performing stocks for the year, how four directors put in $5.1 million to make a quick $1.4 million, what are the hottest stocks on the ASX right now and Dr Boreham’s prognosis of Suda. But fir...

Stockhead ACW 1 year ago
10 at 10: These ASX stocks are jumping ahead this morning

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead ACW 1 year ago
Hot Money Monday: The most in-demand stocks on the ASX right now

Each Monday, Stockhead recaps which stocks are heavily demanded by investors – or running hot. Stockhead uses the Relative Strength Index (RSI), a measurement of comparative buying and selling momentum. A reading of 70 is seen as the level...

Stockhead ACW 1 year ago